➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
Merck
McKesson
Dow
AstraZeneca
McKinsey

Last Updated: September 21, 2020

DrugPatentWatch Database Preview

DIAZOXIDE Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

US ANDA Litigation and Generic Entry Outlook for Diazoxide

A generic version of DIAZOXIDE was approved as diazoxide by E5 PHARMA INC on December 20th, 2019.

  Start Trial

Drug patent expirations by year for DIAZOXIDE
Recent Clinical Trials for DIAZOXIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
National Institutes of Health (NIH)Phase 4
Albert Einstein College of Medicine, Inc.Phase 4
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Phase 4

See all DIAZOXIDE clinical trials

Medical Subject Heading (MeSH) Categories for DIAZOXIDE

US Patents and Regulatory Information for DIAZOXIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abraxis Pharm DIAZOXIDE diazoxide INJECTABLE;INJECTION 071519-001 Aug 26, 1987 DISCN No No   Start Trial   Start Trial   Start Trial
E5 Pharma Inc DIAZOXIDE diazoxide SUSPENSION;ORAL 211050-001 Dec 20, 2019 AB RX No No   Start Trial   Start Trial   Start Trial
Novitium Pharma DIAZOXIDE diazoxide SUSPENSION;ORAL 210799-001 Jul 8, 2020 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Harvard Business School
Moodys
McKesson
Johnson and Johnson
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.